BRIEF-Hims & Hers Health Q3 Revenue USD 401.6 Million Vs. IBES Estimate USD 382.2 Million

Reuters
05 Nov 2024

Nov 04 (Reuters) - Hims & Hers Health Q3 free cash flow USD 79.4 million. * Q3 gross margin 79% * Q3 adjusted EBITDA USD 51.1 million vs. IBES estimate USD 38.6 million * Q3 net income USD 75.6 million vs. IBES estimate USD 11.8 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10